INS and diabetes mellitus: Since the ability of EA to improve glucose tolerance and insulin activity was shown in basic research and clinical trials [8, 9, 14], the combination of the benefit of the insulin-enhancing activity of EA with other oral hypoglycemic agents can thus be considered an alternative method for treating DM [16].